{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:06:57Z","timestamp":1791166017381,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.arr.2015.12.009","type":"journal-article","created":{"date-parts":[[2016,1,21]],"date-time":"2016-01-21T02:15:55Z","timestamp":1453342555000},"page":"114-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Molecular imaging of dopamine transporters"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2602-2518","authenticated-orcid":false,"given":"David J.","family":"Brooks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2015.12.009_bib0005","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/brain\/awh607","article-title":"PET in LRRK2 mutations: comparison to sporadic Parkinson\u2019s disease and evidence for presymptomatic compensation","volume":"128","author":"Adams","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.arr.2015.12.009_bib0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/01.WNL.0000044047.58984.2F","article-title":"Slowing Parkinson\u2019s disease progression: recent dopamine agonist trials","volume":"60","author":"Ahlskog","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.12.009_bib0015","first-page":"266","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"TINS"},{"issue":"July","key":"10.1016\/j.arr.2015.12.009_bib0020","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/1531-8257(200007)15:4<692::AID-MDS1014>3.0.CO;2-V","article-title":"Correlation of Parkinson\u2019s disease severity and duration with I-123-FP-CIT SPECT striatal uptake","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov. Disord."},{"issue":"May","key":"10.1016\/j.arr.2015.12.009_bib0025","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/1531-8257(200005)15:3<503::AID-MDS1013>3.0.CO;2-V","article-title":"Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT imaging: the [123I]-FP-CIT study group","volume":"15","author":"Benamer","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0030","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioural and motor consequences of focal lesions of the basal ganglia in man","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.arr.2015.12.009_bib0035","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00259-007-0621-0","article-title":"Dopamine transporter imaging with [(123)I]FP-CIT SPECT: potential effects of drugs","volume":"35","author":"Booij","year":"2008","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2015.12.009_bib0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/ncpneuro0773","article-title":"Technology insight: imaging neurodegeneration in Parkinson\u2019s disease","volume":"4","author":"Brooks","year":"2008","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.arr.2015.12.009_bib0045","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.expneurol.2003.08.008","article-title":"Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson\u2019s disease","volume":"184","author":"Brooks","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2015.12.009_bib0050","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.20112","article-title":"Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes","volume":"19","author":"Catafau","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0022-510X(00)00279-3","article-title":"Differentiation of Parkinson\u2019s disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT","volume":"175","author":"Druschky","year":"2000","journal-title":"J. Neurol. Sci."},{"issue":"pt. 6","key":"10.1016\/j.arr.2015.12.009_bib0060","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/brain\/123.6.1155","article-title":"Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson\u2019s disease and controls","volume":"123","author":"Eisensehr","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.arr.2015.12.009_bib0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archneur.56.5.529","article-title":"Parkinson disease, the effect of levodopa, and the ELLDOPA trial","volume":"56","author":"Fahn","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2015.12.009_bib0070","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1056\/NEJMoa033447","article-title":"Levodopa and the progression of Parkinson\u2019s disease","volume":"351","author":"Fahn","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2015.12.009_bib0075","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.arr.2015.12.009_bib0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1098-2396(199806)29:2<128::AID-SYN4>3.0.CO;2-9","article-title":"Rapid detection of Parkinson\u2019s disease by SPECT with altropane: a selective ligand for dopamine transporters","volume":"29","author":"Fischman","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.arr.2015.12.009_bib0085","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/brain\/aws174","article-title":"The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow","volume":"135","author":"Goker-Alpan","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.arr.2015.12.009_bib0090","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0969-8051(97)00081-4","article-title":"[125I]beta-CIT-FE and [125I]beta-CIT-FP are superior to [125I]beta-CIT for dopamine transporter visualization: autoradiographic evaluation in the human brain","volume":"24","author":"Gunther","year":"1997","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.arr.2015.12.009_bib0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00259-009-1202-1","article-title":"Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson\u2019s disease who were diagnosed with dopamine PET","volume":"37","author":"Ishibashi","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.arr.2015.12.009_bib0100","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archneur.61.8.1224","article-title":"(123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis","volume":"61","author":"Jennings","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2015.12.009_bib0105","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2015.12.009_bib0110","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp-2011-301695","volume":"83","author":"Kupsch","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2015.12.009_bib0115","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/brain\/119.5.1633","article-title":"Executive and mnemonic functions in early Huntington\u2019s disease","volume":"119","author":"Lawrence","year":"1996","journal-title":"Brain"},{"key":"10.1016\/j.arr.2015.12.009_bib0120","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","article-title":"In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson\u2019s disease","volume":"47","author":"Lee","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2015.12.009_bib0125","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.20748","article-title":"[123I]-FP\/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease","volume":"21","author":"Lorberboym","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1212\/WNL.46.1.231","article-title":"[I-123]beta-CIT SPECT imaging demonstrates bilateral loss of dopamine transporters in hemiparkinsons disease","volume":"46","author":"Marek","year":"1996","journal-title":"Neurology"},{"issue":"December (11)","key":"10.1016\/j.arr.2015.12.009_bib0135","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1212\/WNL.57.11.2089","article-title":"[123I]beta-CIT SPECT imaging assessment of the rate of Parkinson\u2019s disease progression","volume":"57","author":"Marek","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.12.009_bib0140","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.0000000000000424","article-title":"Longitudinal follow-up of SWEDD subjects in the PRECEPT study","volume":"82","author":"Marek","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.12.009_bib0145","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/mds.21159","article-title":"Successful antiparkinsonian medication withdrawal in patients with parkinsonism and normal FP-CIT SPECT","volume":"21","author":"Marshall","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0150","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/01.mnm.0000243374.11260.5b","article-title":"Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging","volume":"27","author":"Marshall","year":"2006","journal-title":"Nucl. Med. Commun."},{"key":"10.1016\/j.arr.2015.12.009_bib0155","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mds.22108","article-title":"Parkinson\u2019s disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT","volume":"24","author":"Marshall","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0160","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.12.009_bib0165","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s002590050295","article-title":"Differential distribution of striatal [123I]b-CIT in Parkinson\u2019s disease and progressive supranuclear palsy, evaluated with single-photon emission tomography","volume":"25","author":"Messa","year":"1998","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.arr.2015.12.009_bib0170","first-page":"584","article-title":"Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers","volume":"41","author":"Mozley","year":"2000","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2015.12.009_bib0175","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2004.037028","article-title":"Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson\u2019s disease","volume":"76","author":"Nagayama","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2015.12.009_bib0180","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/mds.22771","article-title":"Combined use of DAT-SPECT and cardiac MIBG scintigraphy in mixed tremors","volume":"24","author":"Novellino","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archneur.61.6.919","article-title":"Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies","volume":"61","author":"O'Brien","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2015.12.009_bib0190","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1192\/bjp.bp.108.052050","article-title":"Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies","volume":"194","author":"O\u2019Brien","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.arr.2015.12.009_bib0195","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/01.wnl.0000277648.63931.c0","article-title":"Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease","volume":"69","author":"Parkinson Group S","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.12.009_bib0200","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.287.13.1653","article-title":"Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa Parkinson disease progression","volume":"287","author":"Parkinson Study Group","year":"2002","journal-title":"JAMA"},{"issue":"Suppl. 7","key":"10.1016\/j.arr.2015.12.009_bib0205","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/mds.10571","article-title":"Dopamine transporter: basic aspects and neuroimaging","volume":"18","author":"Piccini","year":"2003","journal-title":"Mov. Disord."},{"issue":"November","key":"10.1016\/j.arr.2015.12.009_bib0210","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/1531-8257(200011)15:6<1158::AID-MDS1015>3.0.CO;2-0","article-title":"[I-123]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration","volume":"15","author":"Pirker","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0215","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00702-004-0208-x","article-title":"Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients","volume":"112","author":"Plotkin","year":"2005","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.arr.2015.12.009_bib0220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ana.20160","article-title":"Idiopathic hyposmia as a preclinical sign of Parkinson's disease","volume":"56","author":"Ponsen","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2015.12.009_bib0225","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/brain\/awv215","article-title":"Clinical correlates of raphe serotonergic dysfunction in early Parkinson\u2019s disease","volume":"138","author":"Qamhawi","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.arr.2015.12.009_bib0230","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/01.WNL.0000149403.14458.7F","article-title":"The role of radiotracer imaging in Parkinson\u2019s disease","volume":"64","author":"Ravina","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.12.009_bib0235","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/mds.21685","article-title":"Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs)","volume":"22","author":"Schneider","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0240","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/ana.410380407","article-title":"Decreased single-photon emission computed tomographic [123I]b-CIT striatal uptake correlates with symptom severity in Parkinson's disease","volume":"38","author":"Seibyl","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2015.12.009_bib0245","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp.2009.172825","article-title":"Olfaction in patients with suspected parkinsonism and scans without evidence of dopaminergic deficit (SWEDDs)","volume":"80","author":"Silveira-Moriyama","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2015.12.009_bib0250","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/mds.20141","article-title":"Detection of presymptomatic Parkinson\u2019s disease: combining smell tests, transcranial sonography, and SPECT","volume":"19","author":"Sommer","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0255","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/brain\/awh322","article-title":"Combination of \u2018idiopathic\u2019 REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT","volume":"128","author":"Stiasny-Kolster","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.arr.2015.12.009_bib0260","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/mds.22098","article-title":"[123I]FP-CIT SPET imaging in drug-induced parkinsonism","volume":"23","author":"Tinazzi","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0265","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00415-009-5039-0","article-title":"Clinical and [123I]FP-CIT SPET imaging follow-up in patients with drug-induced parkinsonism","volume":"256","author":"Tinazzi","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.arr.2015.12.009_bib0270","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/mds.21710","article-title":"Accuracy of DaTSCAN ((123)I-ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism: 2-year follow-up of an open-label study","volume":"22","author":"Tolosa","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.arr.2015.12.009_bib0275","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1552-6569.2012.00774.x","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques","volume":"24","author":"Treglia","year":"2014","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.arr.2015.12.009_bib0280","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1136\/jnnp.2006.110122","article-title":"Dementia with lewy bodies: a comparison of clinical diagnosis, FP-CIT SPECT imaging and autopsy","volume":"78","author":"Walker","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2015.12.009_bib0285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1192\/bjp.bp.114.148643","article-title":"Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study","volume":"206","author":"Walker","year":"2015","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.arr.2015.12.009_bib0290","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of PD with ropinirol versus l-dopa: the REAL-PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann. Neurol"}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156816371530043X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156816371530043X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T13:47:03Z","timestamp":1549806423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156816371530043X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":58,"alternative-id":["S156816371530043X"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2015.12.009","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular imaging of dopamine transporters","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2015.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}